SCP-5607
#page-content .collapsible-block { 
    position: relative;
    padding: 0.5em;
    margin: 0.5em;
    box-shadow: 2px 1.5px 1px rgba(176,16,0,0.7), 0 0 0px 1px lightgrey;
    overflow-wrap: break-word;
}
 
.collapsible-block-unfolded{
    color: black;
    overflow-wrap: break-word;
 
}
 
.collapsible-block-unfolded-link {
    text-align:center;
}
 
.collapsible-block-folded {
    text-align: center;
    color: dimgrey;
}
 
.collapsible-block-link {
    font-weight: bold;
    color: dimgrey;
    text-align: center;
}
 
.addendumbox {
    padding: .01em 16px;
    margin-bottom: 16px;
    margin-top: 16px;
    padding-bottom: 1em;
    box-shadow:0 2px 5px 0 rgba(0,0,0,0.16),0 2px 10px 0 rgba(0,0,0,0.12);
}
 
.material-box {
    padding: .01em 16px;
    margin-bottom: 16px;
    margin-top: 16px;
    padding-bottom: 1em;
    border: 1px lightgrey solid;
    box-shadow: 1px 2px 2px 0 rgba(0,0,0,0.16);
}
 
.material-box blockquote {
    border: 1px double #999;
}
 
.wiki-content-table {
    width: 100%;
}
 
.addendumbox blockquote {
    border: 1px double #999;
}
 
.addendumtitle {
   opacity: 0.8;
   margin-bottom: 10px;
   color: #b01;
}
 
.maintitle {
   margin-bottom: 10px;
   color: black;
}
 
.scp-header {
    text-align: center;
    font-size:x-large;
    color:#b01;
}
 
.addenda-header {
    width: 100%;
    border-bottom: 2px black solid;
    color: black;
}
 
.scp-info {
    display:flex;
    justify-content:space-between;
    font-size:large;
}
 
.scp-info-box {
    display:flex; 
    justify-content:space-between;
}
 
.object-info {
    color:black;
    align-self: flex-end;
    font-size: large;
}
 
.title-style {
    opacity: 0.8;
    margin-bottom: 10px;
    color: #b01;
    font-size: large;
    text-decoration: underline;
    font-weight: bold;
}
 
.update-div-empty {
    text-align: right;
    font-size: x-small;
    color: lightgrey;
}
 
.update-div {
    text-align: right;
    font-size: x-small;
}
 
.computed {
    border: 1px black solid;
    width: 50%;
    display: inline-block;
text-align: left;
    padding: 3px;
}
.computed:before {
    content:"Computed Code";
    font-weight: bold;
border-bottom: solid 1px black;
width: 100%;
}
.rawcode {
    border: black solid 1px;
    width: 50%;
    display: inline-block;
text-align: left;
    padding: 3px;
}
.rawcode:before{
    content:"Raw Code";
    text-align: center;
    font-weight: bold;
border-bottom: solid 1px black;
width: 100%;
}
.codebox {
    display: inline-block;
    width: 100%;
    text-align: center;
}
.yui-navset .yui-nav .selected a em,  .yui-navset .yui-nav a em{
        padding: 0.25em .75em; 
        top: 0px;
        margin-bottom: 0px;
}
.yui-navset .yui-nav .selected a {
     background: gray;
}
.yui-navset .yui-nav .selected {
       margin: 0px;
}
.yui-navset .yui-nav .selected a, .yui-navset .yui-nav .selected a:focus, .yui-navset .yui-nav .selected a:hover, .yui-navset .yui-nav .selected a {
         background: gray;
}
.yui-navset .yui-nav a:hover,
.yui-navset .yui-nav a:focus {
    background: gainsboro;
    text-decoration: none;
}
.yui-navset .yui-nav a, .yui-navset .yui-navset-top .yui-nav a {
background-color: none;
background-image: none;
}
.yui-navset .yui-nav a {
background: none;
}
.yui-navset .yui-nav li{
margin: 0px;
}
 
#page-content .licensebox .collapsible-block {
    position: unset;
    padding: unset;
    margin: unset;
    box-shadow: unset;
}
 
.licensebox .collapsible-block-unfolded{
    color: inherit;
}
 
.licensebox .collapsible-block-unfolded-link {
    text-align: left;
}
 
.licensebox .collapsible-block-folded {
    text-align: left;
    color: inherit;
}
 
.licensebox .collapsible-block-link {
    color: inherit;
    text-align: left;
}
rating: +60+x


3/5607 LEVEL 3/5607
CLASSIFIED
classified-bar.svg
classified-bar.svg
classified-bar.svg
classified-bar.svg
classified-bar.svg
classified-bar.svg
Item #: SCP-5607
Safe
Assigned Site Site Director Research Head Assigned MTF
Site-52 Dr. Richard Nylen Dr. Cooper Millgate Epsilon-19 ("Hard Point")

Special Containment Procedures

SCP-5607 is held within a specialized medical stasis unit in Research Lab 14-B, at Site-52. All basic life functions are supported through the stasis unit and maintained by the Research and Development Division.

SCP-5607-1 is to be extracted via a catheter and stored within pressurized biologic storage tanks. The extracted SCP-5607-1 is given to Development Team 14 to be repurposed into Compound-5607/P.

Description

alien

SCP-5607 within its stasis unit.

SCP-5607 is theorized to be an extraplanetary humanoid entity originating from outside of the Sol System. Measuring 11 cm in height, SCP-5607 is bipedal, with elongated arms, and a large head relative to its body (approximately 4 cm in diameter). Similar in biological function to native Earth plants, SCP-5607 subsists off water, UV radiation, and carbon dioxide. Since its discovery, SCP-5607 remains in a self-induced comatose state, though all bodily functions are fully operational.

SCP-5607 was discovered in 1976, during a Foundation-backed mission to the lunar surface. During surveying operations in the Montes Secchi range, astronauts discovered a disk-shaped vessel (designated SCP-5607-0). After SCP-5607 and its stasis container were removed from SCP-5607-0, a self-destruct sequence initiated leading to the destruction of the vessel in its entirety. The salvaged remains were declared unsuitable for experimentation and subsequently left at the point of discovery (2.65°N 42.97°E, Montes Secchi, Earth 1).

ship

SCP-5607-0 prior to its destruction.

SCP-5607-1 is the designation for urine created by SCP-5607 and is currently considered anomalous due to an unexplained biological reaction caused by its inhalation. During the examination of the spacesuit worn by SCP-5607, an unusual urine disposal method was discovered. Utilizing a catheter and an advanced vaporization unit, the suit redistributed vaporized SCP-5607-1 through the respiratory systems. Inhalation of SCP-5607-1 was subsequently tested on 28 different species, including humans. These tests concluded that SCP-5607-1 unilaterally causes a substantial increase in physical and mental dexterity, far beyond pre-exposure parameters. It is theorized that this facilitates the acuity needed for piloting the high-speed interstellar vessel used by SCP-5607.

SCP-5607 Project Proposal

inhale

PISS Device.

The Research and Development Division has developed an inhalation device utilizing Compound-5607/P, an SCP-5607-1 derivative capable of a temporary and substantial increase in the effectiveness of Mobile Task Force agents. The device was designated the Personal Inhalant Service Stimulant, or PISS device. Testing concluded a ~175% increase in performance-related scoring in all participants.1 The R&D division requests the use of a high-engagement Mobile Task Force in order to test the long-term use of the PISS Device.

MTF Administration: Approved

Site Director: Approved

Ethics Committee: Approved

Dr. Cooper Millgate and Development Team 14 are hereby granted a six-month trial for the operational use of PISS Devices utilizing MTF Epsilon-19, under the supervision of Captain Luke Wells. Further stipulations and requirements are available to applicable personnel.































































































THIS SCENARIO WAS BROUGHT TO YOU BY THE FOUNDATION MTF ADMINISTRATION


Say NO to performance-enhancing drugs and ALWAYS report suspicious behavior, regardless of the source.

This situation was extrapolated from real events for training purposes, names and designations have been altered for privacy.


Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License